Search Results - Mark D. Minden

Refine Results
  1. 61
    PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia

    PML/RARα Targets Promoter Regions Containing PU.1 Consensus and RARE Half Sites in Acute Promyelocytic Leukemia by Kankan Wang, Ping Wang, Jiantao Shi, Xuehua Zhu, Miaomiao He, Xiaohong Jia, Xian‐Wen Yang, Fei Qiu, Wen Jin, Maoxiang Qian, Hai Fang, Jian‐Qing Mi, Xuzhi Yang, Huasheng Xiao, Mark D. Minden, Yanzhi Du, Chen Zhu, Ji Zhang

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 62
    Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms

    Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms by Jong Bok Lee, Mark D. Minden, Weihsu C. Chen, Elena Streck, Branson Chen, Hyeonjeong Kang, Andrea Arruda, Dalam Ly, Sandy D. Der, Sohyeong Kang, Paulina Achita, Cheryl D’Souza, Yueyang Li, Richard W. Childs, John E. Dick, Li Zhang

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 63
    The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells

    The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells by Sumaiya Sharmeen, Marko Škrtić, Mahadeo A. Sukhai, Rose Hurren, Marcela Gronda, Xiaoming Wang, Sonali B. Fonseca, Hongxiang Sun, Tabitha E. Wood, Richard A. Ward, Mark D. Minden, Robert A. Batey, Alessandro Datti, Jeffrey L. Wrana, Shana O. Kelley, Aaron D. Schimmer

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 64
    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

    Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment... by Hagop M. Kantarjian, Xavier Thomas, Anna Dmoszyńska, Agnieszka Wierzbowska, Grzegorz Mazur, Jiří Mayer, Jyh-Pyng Gau, Wen‐Chien Chou, Rena Buckstein, Jaroslav Čermák, Ching-Yuan Kuo, Albert Oriol, Farhad Ravandi, Stefan Faderl, Jacques Delaunay, Daniel Lysák, Mark D. Minden, Christopher Arthur

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 65
    Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML

    Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML by Sanduni U. Liyanage, Rose Hurren, Véronique Voisin, Gaëlle Bridon, Xiaoming Wang, Changjiang Xu, Neil MacLean, Thirushi Siriwardena, Marcela Gronda, Dana Yehudai, Shrivani Sriskanthadevan, Daina Avizonis, Aisha Shamas‐Din, Mark D. Minden, Gary D. Bader, Rebecca R. Laposa, Aaron D. Schimmer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 66
    Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers

    Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers by Jorge E. Cortés, Kenji Tamura, Daniel J. DeAngelo, Johann S. de Bono, David Lorente, Mark D. Minden, Geoffrey L. Uy, Hagop M. Kantarjian, Lisa S. Chen, Varsha Gandhi, Robert Godin, Karen Keating, Kristen McEachern, Karthick Vishwanathan, J. Elizabeth Pease, Emma Dean

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 67
    Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

    Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care by Hartmut Döhner, Anna Dolnik, Lin Tang, John F. Seymour, Mark D. Minden, Richard M. Stone, Teresa Bernal, Haifa Kathrin Al‐Ali, Valeria Santini, Paresh Vyas, C.L. Beach, Kyle J. MacBeth, Barry Skikne, S. Songer, Nora Tu, Lars Bullinger, Hervé Dombret

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 68
    Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation

    Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation by Qingfei Jiang, Jane Isquith, M Zipeto, Raymond Diep, Jessica Pham, Nathaniel P. Delos Santos, Eduardo Reynoso, Julisia Chau, Heather Leu, Elisa Lazzari, Etienne Melese, Wenxue Ma, Rongxin Fang, Mark D. Minden, Sheldon Morris, Bing Ren, Gabriel Pineda, Frida Holm, Catriona Jamieson

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 69
    Very long chain fatty acid metabolism is required in acute myeloid leukemia

    Very long chain fatty acid metabolism is required in acute myeloid leukemia by Matthew Tcheng, Alessia Roma, Nawaz Ahmed, Richard Smith, Preethi Jayanth, Mark D. Minden, Aaron D. Schimmer, David A. Hess, Kristin J. Hope, Kevin A. Rea, Tariq A. Akhtar, Eric Bohrnsen, Angelo D’Alessandro, Al‐Walid Mohsen, Jerry Vockley, Paul A. Spagnuolo

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 70
    Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production

    Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production by Jong Bok Lee, Dilshad H. Khan, Rose Hurren, Mingjing Xu, Yoosu Na, Hyeonjeong Kang, Sara Mirali, Xiaoming Wang, Marcela Gronda, Yulia Jitkova, Neil MacLean, Andrea Arruda, Zoe Alaniz, Marina Konopleva, Michael Andreeff, Mark D. Minden, Zhang Li, Aaron D. Schimmer

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 71
    ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia

    ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia by Qingfei Jiang, Leslie Crews, Christian Barrett, Hye-Jung Chun, Angela C. Court, Jane Isquith, M Zipeto, Daniel Goff, Mark D. Minden, Anil Sadarangani, Jessica M. Rusert, Kim-Hien T. Dao, Sheldon Morris, Lawrence S.B. Goldstein, Marco A. Marra, Kelly A. Frazer, Catriona Jamieson

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 72
    Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands

    Selective Inhibition of Histone Deacetylases Sensitizes Malignant Cells to Death Receptor Ligands by Tabitha E. Wood, Shadi Dalili, Craig D. Simpson, Mahadeo A. Sukhai, Rose Hurren, Kika Anyiwe, Xinliang Mao, Fernando Suárez, Marcela Gronda, Yanina Eberhard, Neil MacLean, Troy Ketela, John C. Reed, Jason Moffat, Mark D. Minden, Robert A. Batey, Aaron D. Schimmer

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 73
    Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis

    Inflammatory signals from fatty bone marrow support DNMT3A driven clonal hematopoiesis by Naama Zioni, A. Akhiad Bercovich, Noa Chapal-Ilani, Tal Bacharach, Nadav Rappoport, Adam Solomon, Roi Avraham, Ekaterina Kopitman, Ziv Porat, Mehmet Saçma, G. Hartmut, Marina Scheller, Carsten Müller‐Tidow, Daniel B. Lipka, Ekaterina Shlush, Mark D. Minden, Nathali Kaushansky, Liran I. Shlush

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 74
    Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

    Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia by Guillermo Garcia‐Manero, Sarit Assouline, Jorge E. Cortés, Zeev Estrov, Hagop M. Kantarjian, Hui Yang, Willie Newsome, Wilson H. Miller, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, T. Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory K. Reid, Eric Laille, Robert E. Martell, Mark D. Minden

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 75
    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

    A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies by Aaron D. Schimmer, Susan O’Brien, Hagop M. Kantarjian, Joseph Brandwein, Bruce D. Cheson, Mark D. Minden, Karen Yee, Farhad Ravandi, Francis J. Giles, Andre C. Schuh, Vikas Gupta, Michael Andreeff, Charles Koller, Hong Chang, Suzanne Kamel‐Reid, Mark S. Berger, Jean Viallet, Gautam Borthakur

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 76
    ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis

    ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis by M Zipeto, Angela C. Court, Anil Sadarangani, Nathaniel P. Delos Santos, Larisa Balaian, Hye-Jung Chun, Gabriel Pineda, Sheldon Morris, Cayla Mason, Ifat Geron, Christian Barrett, Daniel Goff, Russell Wall, Maurizio Pellecchia, Mark D. Minden, Kelly A. Frazer, Marco A. Marra, Leslie Crews, Qingfei Jiang, Catriona Jamieson

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 77
    Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death

    Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death by Eric A. Lee, Leonard Angka, Sarah-Grace Rota, Thomas Hanlon, Andrew Mitchell, Rose Hurren, Xiao Ming Wang, Marcela Gronda, Ezel Boyacı, Barbara Bojko, Mark D. Minden, Shrivani Sriskanthadevan, Alessandro Datti, Jeffery L. Wrana, Andrea N. Edginton, Janusz Pawliszyn, Jamie W. Joseph, Joe Quadrilatero, Aaron D. Schimmer, Paul A. Spagnuolo

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 78
    Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

    Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia by Tino Schenk, Weihsu Claire Chen, Stefanie Göllner, Louise Howell, Liqing Jin, Katja Hebestreit, Hans‐Ulrich Klein, Andreea C. Popescu, Alan Burnett, Ken Mills, Robert A. Casero, Laurence J. Marton, Patrick M. Woster, Mark D. Minden, Martin Dugas, Jean Wang, John E. Dick, Carsten Müller‐Tidow, Kevin Petrie, Arthur Zelent

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 79
    A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia

    A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia by Andy G.X. Zeng, Suraj Bansal, Liqing Jin, Amanda Mitchell, Weihsu Claire Chen, Hussein A. Abbas, Michelle Chan‐Seng‐Yue, Véronique Voisin, Peter van Galen, Anne Tierens, Meyling Cheok, Claude Preudhomme, Hervé Dombret, Naval Daver, P. Andrew Futreal, Mark D. Minden, James A. Kennedy, Jean Wang, John E. Dick

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 80
    Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia

    Immune dysfunction signatures predict outcomes and define checkpoint blockade–unresponsive microenvironments in acute myeloid leukemia by Sergio Rutella, Jayakumar Vadakekolathu, Francesco Mazziotta, Stephen Reeder, Tung On Yau, Rupkatha Mukhopadhyay, Benjamin Dickins, Heidi Altmann, Michael Krämer, Hanna A. Knaus, Bruce R. Blazar, Vedran Radojčić, Joshua F. Zeidner, Andrea Arruda, Bofei Wang, Hussein A. Abbas, Mark D. Minden, Sarah K. Tasian, Martin Bornhäuser, Ivana Gojo, Leo Luznik

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: